Exemever

Exemever

67.27

Substance: Exemestane
Package: 25 mg (25 pills)

SKU: 922 Category: Tag:

Purchase Exemever (Exemestano) in UK

Exemever (Exemestane) is an oral medication prescribed for the treatment of breast cancer in postmenopausal women. It works to reduce estrogen levels to stop or slow the growth of tumors that are thought to use this growth hormone. The doctor may also prescribe this drug to treat other unlisted conditions.

Exemever (Exemestane) Dosage

Strictly use Exemever (Exemestane) as prescribed by your doctor for best results. The dosage and frequency of administration will be determined on the basis of symptoms and current health conditions. Do not self-medicate or deviate from these instructions, as misuse can cause serious health complications. Swallow the tablets whole and unaffected with a full glass of water after a meal or snack to avoid an upset stomach. Do not alter the shape of the drug by chewing, dividing, or dissolving in water as this can destroy the contents or change their effects.

Side Effects Exemever (Exemestane)

The use of Exemever (Exemestane) may cause side effects in some patients. These can vary widely in intensity and should always be discussed with your UK doctor as soon as possible. Side effects that can occur include:

Headache

Drowsiness

Hot flashes or hot flashes

Increased sweating

Stomach ache

Constipation

Diarrhea

Agitation

The Depression

Muscle pain or weakness

Insomnia or other sleep disturbances

Blur, or tunnel vision

Swelling or pain in the extremities

Shortness of breath

Chest tightness, chest pain, difficulty in breathing

Difficulty speaking or balancing

Exemever (Exemestane) should be used by women who have not gone through menopause, are pregnant, breastfeeding, or are lactose intolerant. Also reveal if you have osteoporosis, decreased liver function, or reduced kidney function to make sure you make any necessary adjustments to your dosage.

There are no reviews yet.

Be the first to review “Exemever”

Your email address will not be published. Required fields are marked *

*